Serial Number | 97081506 |
Word Mark | TETRAX |
Filing Date | Tuesday, October 19, 2021 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, January 15, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 18, 2023 |
Goods and Services | custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies; Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines and antibodies for others |
Goods and Services | pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the diagnosis, prevention and treatment of cancer; Antibodies being pharmaceutical preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; Vaccines; Pharmaceutical preparations for cell therapy; Preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes |
Goods and Services | biochemicals, namely, antibody-derived antigen binding molecules and antibody-derived recombinant antigen binding molecules for in vitro scientific or research use |
Goods and Services | custom design and engineering of antibody-derived antigen binding molecules and antibody-derived recombinant antigen binding molecules; Providing a bioinformatics platform as a service (PAAS) featuring computer software for developing antibody-derived antigen binding molecules and antibody-derived recombinant antigen binding molecules; Custom design and engineering of antibodies; Custom design and engineering of antigens; Antibody engineering; Biochemical research and development; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development and establishment of testing specifications and procedures in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the development of new cancer therapies; Scientific research in human and animal cell therapy; Platform as a service (PAAS) featuring computer software platforms for analysis of bioinformatic data |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Monday, March 13, 2023 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, March 13, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Monday, March 13, 2023 |
Primary Code | 040 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, March 13, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | SYNERGY IMT, INC. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Kirkland, WA 980337105 |
Party Name | SYNERGY IMT, INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Kirkland, WA 980337105 |
Event Date | Event Description |
Tuesday, January 16, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, January 15, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, June 13, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, April 18, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, April 18, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, March 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, March 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 8, 2023 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, March 8, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, March 8, 2023 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, March 8, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Monday, August 1, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, August 1, 2022 | NON-FINAL ACTION E-MAILED |
Monday, August 1, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, July 26, 2022 | ASSIGNED TO EXAMINER |
Friday, November 5, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, October 22, 2021 | NEW APPLICATION ENTERED |